| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| LogicBio Therapeutics, Inc. | President, CEO, Director | Common Stock | 0 | $2.01 | 16 Nov 2022 | Direct | |
| LogicBio Therapeutics, Inc. | President, CEO, Director | Stock Option (right to buy) | 0 | 16 Nov 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| LOGC | LogicBio Therapeutics, Inc. | 16 Nov 2022 | 3 | $0 | 4 | President, CEO, Director | 17 Nov 2022, 20:10 |
| LOGC | LogicBio Therapeutics, Inc. | 01 Mar 2022 | 1 | $0 | 4 | President and Chief Executive, Director | 03 Mar 2022, 16:54 |